Dr. Marci Helen Levine

DMD MD | Dentist



  
  726 Broadway, Suite 350, New York
  New York, 10003-9502

  212-443-1300    Maps & Directions
Dr. Marci Helen Levine is a New York, New York based Dentist who is specialized in Dentistry. She may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. Her current practice location is 726 Broadway, Suite 350, New York. Patients can reach her at 212-443-1300.
Dr. Marci Helen Levine is the primary dental care provider for patients of all ages. She is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Marci Helen Levine speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Marci Helen Levine
Specialization: Dentist
Gender:Female
Credentials: DMD MD
Accepts Medicare Assignment:May Accept
Practice Address:726 Broadway, Suite 350, New York,
New York, 10003-9502
Phone:212-443-1300
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 6901177732
Enrollment ID: I20170811002198
NPI Number: 1255321931
NPI Enumeration Date: 25 Oct, 2005
NPI Last Update On: 31 Mar, 2015

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 350 E 79th St, Apt 28d
New York, New York
Zip: 10075-9202
Phone Number: 646-957-7217
Patients can reach Dr. Marci Helen Levine at 726 Broadway, Suite 350, New York, New York or can call to book an appointment on 212-443-1300. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: